Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 8,135 | 8,103 | 8,118 | 8,042 | 8,078 |
| Income taxes - deferred | -218 | -449 | -655 | 251 | -4,029 |
| Accounts receivable | 1,390 | 2,383 | 4,425 | 763 | -1,104 |
| Accounts payable and accrued liabilities | 309 | 694 | -2,065 | 246 | 695 |
| Other Working Capital | 760 | 1,954 | 2,447 | 2,268 | -623 |
| Other Operating Activity | -3,551 | -3,729 | -3,988 | -414 | 3,387 |
| Operating Cash Flow | $6,825 | $8,956 | $8,282 | $11,156 | $6,404 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -45 | -57 | -37 | -7 | -2 |
| Net Acquisitions | -2,825 | -1,825 | -2,825 | -4,325 | -2,825 |
| Purchase Sale Intangibles | -1,975 | -475 | -213 | -363 | -107 |
| Investing Cash Flow | $-4,845 | $-2,357 | $-3,075 | $-4,695 | $-2,934 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,348 | -1,360 | -1,363 | -1,250 | -137,890 |
| Common Stock Issued | 0 | 37,329 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | N/A | N/A | 0 | -686 |
| Dividend Paid | -1,166 | -1,022 | -1,001 | N/A | N/A |
| Other Financing Activity | -301 | -2,242 | -1,000 | -4,047 | 99,602 |
| Financing Cash Flow | $-2,815 | $32,705 | $-3,364 | $-5,297 | $-38,974 |
| Exchange Rate Effect | -130 | 192 | 39 | -141 | 174 |
| Beginning Cash Position | 52,308 | 12,812 | 10,930 | 9,907 | 45,237 |
| End Cash Position | 51,343 | 52,308 | 12,812 | 10,930 | 9,907 |
| Net Cash Flow | $-835 | $39,304 | $1,843 | $1,164 | $-35,504 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,825 | 8,956 | 8,282 | 11,156 | 6,404 |
| Capital Expenditure | -2,020 | -532 | -250 | -370 | -109 |
| Free Cash Flow | 4,805 | 8,424 | 8,032 | 10,786 | 6,295 |